Rss Feed

Subscribe to Rss Feed feed
Latest Medical Research News and Research
Updated: 12 min 25 sec ago

Dance alleviates perceived symptoms of depression, study finds

Thu, 10/30/2025 - 07:44
Dance as a performative art form alleviates perceived symptoms of depression, helps to understand its root causes and promotes self-actualization, a recent study from the University of Eastern Finland found.

Pharmacists can help control blood sugar in cancer patients with diabetes

Thu, 10/30/2025 - 07:39
People with cancer who received diabetes care from clinical pharmacists achieved significantly better blood sugar control, according to new research from the University of California San Diego.

Football hits leave lasting brain changes

Thu, 10/30/2025 - 07:35
Recent MRI research reveals how repeated football head impacts reshape brain structures, offering insights into chronic traumatic encephalopathy (CTE) risk.

Babies' gut bacteria could play a role in programming brain circuits tied to emotional health

Thu, 10/30/2025 - 07:30
A child's early gut microbiome may influence their risk of developing depression, anxiety or other internalizing symptoms in middle childhood, according to a new UCLA Health study.

Scientists uncover why many cancer patients develop chemotherapy-induced neuropathy

Thu, 10/30/2025 - 06:58
Scientists at Wake Forest University School of Medicine, in collaboration with researchers at Weill Cornell Medicine, have made a breakthrough in understanding why many cancer patients develop nerve damage after chemotherapy.

Breakthrough could offer a new therapeutic option for stopping diabetes-induced complications

Thu, 10/30/2025 - 06:54
Researchers from the University at Albany and NYU Grossman School of Medicine have found a way to block a key cellular pathway known to drive chronic inflammation and impaired wound healing in people with diabetes.

Veterans with post-traumatic brain injury epilepsy more likely to have higher mortality rates

Thu, 10/30/2025 - 06:50
Military veterans who develop epilepsy after a traumatic brain injury may have a higher mortality rate in the following years than veterans who develop epilepsy with no previous traumatic brain injury, according to a study published on October 29, 2025, in Neurology®, the medical journal of the American Academy of Neurology.

New study sheds light on vision loss in idiopathic intracranial hypertension

Thu, 10/30/2025 - 06:44
If untreated, a disorder of high brain pressure called idiopathic intracranial hypertension can lead to vision loss. But this disorder can develop without noticeable symptoms, making it hard to catch.

Research identifies biomarkers in blood to fine-tune breast cancer interventions

Thu, 10/30/2025 - 00:55
Doctors may be able to spare patients unnecessarily aggressive breast cancer treatments by collecting and testing cancer cells in patients' blood, research from the University of Michigan and the University of Kansas suggests.

Study links short-term blood pressure variability to Alzheimer's-related brain loss

Thu, 10/30/2025 - 00:37
Even when blood pressure is well controlled, older adults whose blood pressure fluctuates widely from one heartbeat to the next may be at greater risk for brain shrinkage and nerve cell injury, according to a new study led by the USC Leonard Davis School of Gerontology.

Antibiotic use within 24 hours of birth reduces wound severity in childbirth injuries

Thu, 10/30/2025 - 00:32
Giving antibiotics to women within 24 hours of an obstetric tear during childbirth is associated with a reduced risk of larger/clinically relevant wound complications, find the results of a clinical trial from Denmark published by The BMJ today.

Stem cells show promise in preventing post-heart attack heart failure

Thu, 10/30/2025 - 00:20
Patients with weak heart function who receive stem cell therapy shortly after a heart attack are at lower risk of developing heart failure and related hospital stays compared with standard care, finds a clinical trial published by The BMJ today.

WHO reviews highlight limited long-term data on GLP-1 drug safety

Thu, 10/30/2025 - 00:04
Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies raise questions. The reviews were commissioned by the World Health Organization (WHO) to inform upcoming guidelines on the use of these drugs to treat obesity.

Diets that harm the planet also raise the risk of cancer, heart disease, and diabetes

Wed, 10/29/2025 - 21:15
Diets that place greater pressure on the environment, high in meat and low in plant foods, were linked to higher risks of cancer, coronary heart disease, and type 2 diabetes in over 34,000 French adults. Sustainable, plant-rich diets were associated with better health and lower environmental impact.

Diabetes remission possible with GLP-1 drugs, Italian study confirms

Wed, 10/29/2025 - 20:25
In a large real-world Italian cohort, GLP-1 receptor agonist therapy led to measurable rates of type 2 diabetes remission, depending on how remission was defined. The most pragmatic definition (Remission 3) was linked to improved glycemia, weight, and a lower risk of microvascular and cardiovascular events.

Eating habits tied to Parkinson’s risk: sweets and processed meats raise odds, fruit lowers them

Wed, 10/29/2025 - 19:38
In a large Italian case-control study, researchers identified data-driven dietary patterns linked to Parkinson’s disease risk. Diets rich in sweets, red and cured meats were associated with higher odds of PD, while fruit, especially citrus, was protective.

Aligning your body clock may protect your heart and metabolism, says AHA

Wed, 10/29/2025 - 19:13
A new American Heart Association scientific statement highlights how maintaining circadian health through regular sleep, light exposure, meal timing, and exercise may reduce cardiometabolic disease risk. Disrupting these daily rhythms can impair glucose regulation, blood pressure, and cardiovascular function.

Scripps Research professor wins $3.2 million grant to unravel the mysteries of type 1 diabetes

Wed, 10/29/2025 - 16:09
Luc Teyton, professor in the Department of Immunology and Microbiology at Scripps Research, has received a five-year, $3.2 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to help answer how type 1 diabetes manifests and develop potential therapeutics to reverse or prevent the disease.

Rapamycin shows promise in treating cold tumors with specific gene mutation

Wed, 10/29/2025 - 16:04
Immune checkpoint inhibitors (ICIs) emerged in the US about 15 years ago as an exciting class of cancer treatments that have achieved complete and durable remissions for thousands of people with end-stage metastatic cancers.

Targeting myeloid cells to enhance cancer immunotherapy

Wed, 10/29/2025 - 16:00
Mayo Clinic researchers have identified a specific immune cell that can be targeted to give a boost to standard immunotherapies for cancer. Two

Pages